The epidemic of the acquired immune deficiency syndrome (AIDS) and infection with human immunodeficiency virus (HIV) necessitates early planning of services and allocation of resources. The use of hospital resources by patients with AIDS and the planned additional costs of clinical and preventive services for the epidemic of infection with HIV were calculated for an inner London health district that has treated 18% of the cases in the United Kingdom. Patients with AIDS required on average 50 days of inpatient hospital care each at an estimated current average lifetime cost of £6800. These costs, however, underestimated the additional capital and revenue costs of planned new preventive and treatment services, estimated as being £388 000 revenue and £472 000 capital for 1986-7. It is important to invest now in preventive services throughout the United Kingdom to reduce the future social and financial costs of AIDS.
Introduction
Professional and public opinion has recently drawn attention to the need for health care planning and financing for the acquired immune deficiency syndrome (AIDS) and the underlying epidemic of infection with human immunodeficiency virus (HIV) (this virus was previously known as human T lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV)).'-' The resource costs of AIDS and infection with HIV go far beyond those required for inpatient and outpatient care and include those required for preventive strategies, whether national or local, collective or individual. They also include the costs of screening blood donations for HIV antibody; heat treating blood products; upgrading laboratory facilities; providing dental services for patients positive for HIV antibody; tightening up policies to control infectious diseases; and training staff.
There is evidence that the spread of HIV has been rapid in high risk groups, particularly in London.48 Health care planning for AIDS and infection with HIV is hampered, however, by lack of information about the size of the populations at high risk. It is evident that those who have been infected by the virus greatly outnumber those with AIDS, and an estimated 10 000-20 000 people are already infected in the United Kingdom.9 Their prognosis is uncertain because the true length of the incubation period from infection to the appearance ofAIDS is not yet known and may, when the clinical course of the disease is fully understood, turn out to be longer than was initially thought'01' (D N Lawrence et al, international conference on AIDS, Atlanta, Georgia, April 1985) . This means that current estimates of the proportion of people with infection with HIV who will eventually develop AIDS may be too low. In a study of five cohorts of patients infected by HIV the three year incidence of AIDS ranged from 8 1% to 34-2%. 2 In view of the projected increase in the number of cases of AIDS'" and in the underlying pool of HIV infection regions and districts will need to plan their services and allocate appropriate resources. Bloomsbury Health District, in inner London, has treated 18% of the cases of AIDS in the United Kingdom to date. We present our estimates of the costs of services that have been provided for these patients and attempt to identify the information necessary for planning preventive and treatment services and resource allocation for this condition.
Resource use by patients with AIDS Thirty three cases of AIDS (as defined by the Centers for Disease Control) treated in Bloomsbury hospitals to the end of June 1985 were available for analysis. Fifteen patients had Kaposi's sarcoma, 11 Pneumocystis carinti pneumonia, four Kaposi's sarcoma and P carinii pneumonia, and three other opportunistic infections. The resources used by these patients were estimated by extracting data retrospectively from hospital inpatient and outpatient notes, using a structured form. Twenty nine of the 33 patients received inpatient hospital care. For each case the number of admissions and length of stay were recorded. The total number of weeks under the supervision of the hospital, defined as the time from presentation with symptoms leading to a diagnosis of AIDS to death, transfer to another district, or completion of this study was also recorded.
A total of 67 hospital admissions were recorded for the 29 inpatients, accounting for 1155 hospital inpatient days. Mean length of stay was 17 2 days (median 13, range 1-54 days). Of the 67 admissions, three were for intensive care, with an average length of stay of 10 days. Twenty seven patients received all their treatment in the district, accounting for a total of 949 weeks of follow up and occupying on average 1 1 bed days per week of follow up.
For 16 of the 33 cases the "lifetime" use of resources could be estimated as they had been followed up from diagnosis to death. These patients were followed up for a mean of 22-4 weeks (median 22-5, range 1-47 weeks), during which they occupied a mean of 50 (median 47-5, range 4-108) bed days each. Four died at home. Ten required bronchoscopy, six sigmoidoscopy, two gastroscopy, and two colonoscopy. Two required lymph node biopsy and three required other operations necessitating general anaesthesia.
The figure shows trends in bed use by the 29 patients admitted in the district from March 1983 to June 1985. By June 1985 average bed occupancy was 2-5 beds but maximum bed occupancy was five beds. Mean bed occupancy taken alone underestimates the impact ofAIDS on inpatient care. 23 AUGUST 1986 patients were treated was £126. The marginal cost (that is, the extra cost of treating one more case) may be small at the start of an epidemic, when one or two cases can be managed on existing medical wards. This cost increases substantially, however, when it becomes necessary to invest in extra staff or equipment to deal with the problem.
5-
As pressure on side wards, where patients with AIDS have been managed, increased in the district plans were made for a dedicated facility to provide a comprehensive service for these patients. Because 
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Implementation of precautions is time consuming, and districts treating many scropositive patients will need to consider whether to provide dedicated facilities. The table (D) shows the estimated cost of providing a full time service to meet the needs in this teaching district.
PROTECTION AND EDUCATION OF STAFF AND UPGRADING OF LABORATORIES
Worldwide concern has been expressed about precautions to be taken by staff dealing with patients infected with HIV. Pooled evidence suggests that the risk of nosocomial infection is small," but staff require information updates and training in policy for controlling infectious diseases. Interim guidelines of the Advisory Committee on Dangerous Pathogens set out standards of protection for laboratories working with material infected with HIV. In particular, they recommend category III containment in laboratories dealing with large numbers of infected specimens. The table (E) shows estimates of the cost of upgrading district laboratories to standards recommended by the committee.
TOTAL COSTS
The table (F) summarises the estimated additional costs of a comprehensive service in the district for 1986-7. This amounts to a capital cost of £287 000 and a revenue cost of £388 000.
Discussion
This study aimed to provide preliminary information and principles for planners who have to prepare for the future impact of infection with HIV on health services, though we recognise that the details presented here are specific to a London teaching district. The management of patients with AIDS is only a part of the problem. Estimates of lifetime resource use by patients with AIDS that are based on early cases may be underestimates, as they will tend to select disproportionately patients with shorter survival times (though not necessarily with less inpatient requirements). Costing could alternatively be based on bed days per week of treatment related to mean survival but would be biased towards higher estimates as bed use is higher in the terminal phase of illness. We emphasise that the average costings relate to current practices and ignore the higher marginal costs that would be imposed by greater nursing dependency and capital investment if new inpatient facilities were established. They also ignore costs of community health voluntary and social services. Home care was organised through existing district nurses, social services, and a home terminal care team. In future the district may consider employing a community nurse to facilitate coordination of hospital and home care.
Scitovsky et al reported a lifetime average of 28 -6 inpatient days from diagnosis to death in San Francisco (international conference on AIDS, Georgia, April 1985) compared with 50 in this study, although this study included days spent in hospital for investigation before firm diagnosis. The average lifetime cost per case not requiring intensive care was $24 000 in San Francisco. This is equivalent to £13 032 at 1983 exchange rates and parity of purchasing power. ' Hurst estimated on the basis of 1977 figures that the unit cost for short stay admissions was 213 times higher in the United States than in England, even though length of stay per admission was longer in England.' Thus the current cost estimate of £6838 in this study seems to be broadly compatible with findings of the San Francisco study.
Hardy et al estimated much higher lifetime costs per case,' but these were based on the assumption that the length of stay per admission was 31 days, which is much higher than the observed value of 11 4 days in San Francisco and 17 4 days in this study. The lower figure in San Francisco may reflect the substantial efforts that have been made in that city to coordinate inpatient, outpatient, community, and terminal care, which may reduce the time that a patient needs to stay in hospital. Planners in this country will have to consider financial investment in care outside hospital, and alternative options for care, including home and hospice care, require costing. The establishment of a dedicated ward will make more accurate marginal costing possible.
Of A 64 year oldpatient in good health has macular degeneration ofthe retina which has made herleft eye uselessfor reading. Can anything be done to preserve the right eye orpostpone similar degeneration?
Age related senile macular degeneration is the commonest cause of registrable blindness in England.' Two main types of senile macular degeneration are recognised: disciform ("exudative") degeneration and geographic atrophy of the pigment epithelium ("dry" degeneration). Disciform senile macular degeneration is caused by the invasion of the subretinal space by choroidal new vessels and results in serous elevation of the retina, subretinal haemorrhage, and eventually scarring; loss of central vision is rapid and often profound. On the other hand, geographic atrophy of the pigment epithelium is slower in onset and is generally less disabling than disciform senile macular degeneration. Recently published results of treatment trials of disciform senile macular degeneration from Moorfields and from other centres have shown that the destruction of the new vessels by laser photocoagulation is beneficial so long as the new vessels do not extend under the centre of the fovea (point of fixation).24 Natural history studies have shown that patients with disciform senile macular degeneration in one eye are likely to develop a similar lesion in the other eye at a rate of 12-15% a year.5 When this happens the macular area becomes raised by serous fluid and the patient experiences distortion of vision often before central vision deteriorates.
No preventive measures or drugs have been shown to be of benefit; however, patients such as this woman are advised to look carefully for any distortion of straight lines (such as window frames, crossword puzzles, etc) and to report any such changes immediately. Rapid referral to an ophthalmologist is essential, as over 50% ofpatients seen within two to three weeks ofthe onset of their symptoms can be treated.6 Unfortunately, such is the usual delay in referral that only 5-10%/o of patients seen in the British ophthalmic centres are currently regarded as suitable for treatment. Clearly, increased awareness of the problem by the medical and lay public would improve the prognosis in this large and growing number of patients.-ZDENEK J GREGOR, consultant ophthalmic surgeon, London.
